Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
GENETICS / CLINICAL RESEARCH
A multi-stage genomic approach to uncover druggable gene targets and neural pathways in postpartum depression
1
Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China
Submission date: 2025-02-24
Final revision date: 2025-05-12
Acceptance date: 2025-06-08
Online publication date: 2025-06-22
Corresponding author
Zhi-Yuan Chen
Department of Anesthesiology The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian Province, 362000 China
Department of Anesthesiology The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian Province, 362000 China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Postpartum depression (PPD) is a severe emotional disorder affecting women worldwide, with significant impacts on maternal and infant health. Its genetic contributors and biological mechanisms are poorly understood. Identifying druggable genes and clarifying their causal roles may offer insights for developing more effective treatments.
Material and methods:
We identified drug-related genes and screened gene expression quantitative trait loci (eQTL) from the eQTLGen consortium and genotype tissue expression (GTEx) v8 dataset, focusing on 13 brain tissues, along with Qi et al.’s meta-study on the cerebral cortex. Mendelian randomization (MR) analyses were used to investigate causal relationships between gene expression and PPD risk. Replication analyses in an independent PPD cohort validated initial findings, and meta-analysis combined MR results. Summary-data-based MR (SMR) and heterogeneity in dependent instruments (HEIDI) tests were also performed, followed by colocalization analyses to assess shared causal variants. Mediation analyses were conducted to explore how genetic effects may influence brain connectivity patterns.
Results:
From 5,883 druggable genes, 37 showed potential causal links to PPD. Replication analyses confirmed 9 of these genes, with 4 remaining significant in meta-analysis. SMR and HEIDI analyses focused on CLCN7, which showed robust evidence for causal involvement in PPD. Colocalization analyses suggested shared causal variants, and mediation analyses revealed that CLCN7’s genetic risk is partially mediated by left- to right-hemisphere visual network white-matter structural connectivity.
Conclusions:
Our analysis identified CLCN7 as a potential causal factor in PPD, with its effect mediated through brain connectivity. These findings offer targets for future studies and therapeutic strategies for PPD.
Postpartum depression (PPD) is a severe emotional disorder affecting women worldwide, with significant impacts on maternal and infant health. Its genetic contributors and biological mechanisms are poorly understood. Identifying druggable genes and clarifying their causal roles may offer insights for developing more effective treatments.
Material and methods:
We identified drug-related genes and screened gene expression quantitative trait loci (eQTL) from the eQTLGen consortium and genotype tissue expression (GTEx) v8 dataset, focusing on 13 brain tissues, along with Qi et al.’s meta-study on the cerebral cortex. Mendelian randomization (MR) analyses were used to investigate causal relationships between gene expression and PPD risk. Replication analyses in an independent PPD cohort validated initial findings, and meta-analysis combined MR results. Summary-data-based MR (SMR) and heterogeneity in dependent instruments (HEIDI) tests were also performed, followed by colocalization analyses to assess shared causal variants. Mediation analyses were conducted to explore how genetic effects may influence brain connectivity patterns.
Results:
From 5,883 druggable genes, 37 showed potential causal links to PPD. Replication analyses confirmed 9 of these genes, with 4 remaining significant in meta-analysis. SMR and HEIDI analyses focused on CLCN7, which showed robust evidence for causal involvement in PPD. Colocalization analyses suggested shared causal variants, and mediation analyses revealed that CLCN7’s genetic risk is partially mediated by left- to right-hemisphere visual network white-matter structural connectivity.
Conclusions:
Our analysis identified CLCN7 as a potential causal factor in PPD, with its effect mediated through brain connectivity. These findings offer targets for future studies and therapeutic strategies for PPD.
REFERENCES (41)
2.
Bhusal CK, Bhattarai S, Shrestha A, Sharma HR. Depression and its determinants among postpartum mothers attending at Universal College of Medical Sciences and Teaching Hospital, Bhairahawa, Rupandehi, Nepal. Int J Pediatr 2023, 2023: 1331641.
3.
Ahmed GK, Elbeh K, Shams RM, Malek MAA, Ibrahim AK. Prevalence and predictors of postpartum depression in Upper Egypt: a multicenter primary health care study. J Affect Disord 2021; 290: 211-8.
4.
Attia Hussein Mahmoud H, Lakkimsetti M, Barroso Alverde MJ, et al. Impact of paternal postpartum depression on maternal and infant health: a narrative review of the literature. Cureus 2024; 16: e66478.
5.
Guintivano J, Byrne EM, Kiewa J, et al. Meta-analyses of genome-wide association studies for postpartum depression. Am J Psychiatry 2023; 180: 884-95.
6.
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23: R89-98.
7.
Huang G, Qian D, Liu Y, Qu G, Qian Y, Pei B. The association between frailty and osteoarthritis based on the NHANES and Mendelian randomization study. Arch Med Sci 2023; 19: 1545-50.
8.
Lessard S, Chao M, Reis K, et al. Leveraging large-scale multi-omics evidences to identify therapeutic targets from genome-wide association studies. BMC Genom 2024; 25: 1111.
9.
Pavlides JM, Zhu Z, Gratten J, McRae AF, Wray NR, Yang J. Predicting gene targets from integrative analyses of summary data from GWAS and eQTL studies for 28 human complex traits. Genome Med 2016; 8: 84.
10.
Cheng B, Zhou Y, Kwok VPY, et al. Altered functional connectivity density and couplings in postpartum depression with and without anxiety. Soc Cognitive Affect Neurosci 2022; 17: 756-66.
11.
Deligiannidis KM, Sikoglu EM, Shaffer SA, et al. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res 2013; 47: 816-28.
12.
Freshour SL, Kiwala S, Cotto KC, et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucl Acids Res 2021; 49: D1144-51.
13.
Finan C, Gaulton A, Kruger FA, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med 2017; 9: eaag1166.
14.
Zhang C, He Y, Liu L. Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization. J Headache Pain 2024; 25: 100.
15.
Võsa U, Claringbould A, Westra HJ, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 2021; 53: 1300-10.
16.
Consortium G: The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science (New York, NY) 2020; 369: 1318-30.
17.
Qi T, Wu Y, Fang H, et al. Genetic control of RNA splicing and its distinct role in complex trait variation. Nat Genet 2022; 54: 1355-63.
18.
Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018; 7: e34408.
19.
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613: 508-18.
20.
Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 2018; 362: k601.
21.
Burgess S, Foley CN, Allara E, Staley JR, Howson JMM. A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat Commun 2020; 11: 376.
22.
Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 2011; 40: 755-64.
23.
Bowden J, Spiller W, Del Greco MF, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol 2018; 47: 2100.
24.
Huang Z, He G, Sun S, Feng Y, Huang Y. Causal associations of ambient particulate matter 10 and Alzheimer’s disease: result from a two-sample multivariable Mendelian randomization study. Arch Med Sci 2024; 20: 1604-18.
25.
Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet 2016; 48: 481-7.
26.
Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 2014; 10: e1004383.
27.
Hormozdiari F, van de Bunt M, Segrè AV, et al. Colocalization of GWAS and eQTL signals detects target genes. Am J Hum Genet 2016; 99: 1245-60.
28.
Sanderson E, Richardson TG, Hemani G, Davey Smith G. The use of negative control outcomes in Mendelian randomization to detect potential population stratification. Int J Epidemiol 2021; 50: 1350-61.
29.
Flanders WD, Waller LA, Zhang Q, Getahun D, Silverberg M, Goodman M. Negative control exposures: causal effect identifiability and use in probabilistic-bias and bayesian analyses with unmeasured confounders. Epidemiology 2022; 33: 832-9.
30.
Yook V, Yoo J, Han K, et al. Association between pre-pregnancy tobacco smoking and postpartum depression: a nationwide cohort study. J Affect Disord 2022; 316: 56-62.
31.
Qiu X, Sun X, Li HO, Wang DH, Zhang SM. Maternal alcohol consumption and risk of postpartum depression: a meta-analysis of cohort studies. Public Health 2022; 213: 163-70.
32.
Silverman ME, Smith L, Lichtenstein P, Reichenberg A, Sandin S. The association between body mass index and postpartum depression: a population-based study. J Affect Disord 2018; 240: 193-8.
33.
Yuan M, Chen H, Chen D, et al. Effect of physical activity on prevention of postpartum depression: a dose-response meta-analysis of 186,412 women. Front Psychiatry 2022; 13: 984677.
34.
Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucl Acids Res 2021; 49: D605-12.
35.
Xu M, Tang J, Sun Q, et al. CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway. Arch Med Sci 2024; 20: 1655-71.
36.
Bose S, He H, Stauber T. Neurodegeneration upon dysfunction of endosomal/lysosomal CLC chloride transporters. Front Cell Develop Biol 2021; 9: 639231.
37.
Maurizi A, Capulli M, Curle A, et al. Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications. Bone Res 2019; 7: 17.
38.
Zhang S, Wang W, Wang G, et al. Aberrant resting-state interhemispheric functional connectivity in patients with postpartum depression. Behav Brain Res 2020; 382: 112483.
39.
Chen K, Yang J, Li F, et al. Molecular basis underlying default mode network functional abnormalities in postpartum depression with and without anxiety. Hum Brain Mapping 2024; 45: e26657.
40.
Moses-Kolko EL, Perlman SB, Wisner KL, James J, Saul AT, Phillips ML. Abnormally reduced dorsomedial prefrontal cortical activity and effective connectivity with amygdala in response to negative emotional faces in postpartum depression. Am J Psychiatry 2010; 167: 1373-80.
41.
Dwivedi Y, Zhang H. Altered ERK1/2 signaling in the brain of learned helpless rats: relevance in vulnerability to developing stress-induced depression. Neural Plasticity 2016; 2016: 7383724.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
